Pronanosome Nio-Cat formulation is designed to obtain niosomes positively charged (cationic niosomes). Cationic nanovesicles can be endocyted by cells to achieve intracellular delivery. Cationic niosomes can be also employed in other applications as: drug delivery and targeting, delivery of peptides, drug and proteins, studying of inmune response, dermal or transdermal delivery, cosmetics, functional foods, nutraceuticals, …

Cationic niosomes have advantages such as:

• They are osmotically active and stable.
• They increase the stability of the entrapped drug
• Handling and storage of niosomes do not require any special conditions
• Increased stability due to the surface electric charge
• Can increase the oral bioavailability of drugs
• Can enhance the skin penetration of drugs
• They can be used for oral, parenteral as well topical.
• Niosomes are biodegradable, biocompatible, and non-immunogenic.
• Can be easily endocytosed by cells
•  Improve the therapeutic performance of the drug by protecting it from the biological environment.
•  The niosomal dispersions in an aqueous phase can be emulsified in a non-aqueous phase to control the release rate of the drug and administer normal vesicles in external non-aqueous phase.